Effects of tibolone on the breast of postmenopausal women (Q36885708)

16 August 2017

1 reference

title

Effects of tibolone on the breast of postmenopausal women (English)

1 reference

16 August 2017

Peng-Hui Wang

1

1 reference

16 August 2017

Ming-Huei Cheng

series ordinal

2

1 reference

16 August 2017

Hsiang-Tai Chao

series ordinal

3

1 reference

16 August 2017

Kuan-Chong Chao

series ordinal

4

1 reference

16 August 2017

1 June 2007

1 reference

Taiwanese Journal of Obstetrics & Gynecology

16 August 2017

1 reference

16 August 2017

46

1 reference

16 August 2017

2

1 reference

16 August 2017

121-126

1 reference

Hormones and breast cancer

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Breast cancer risk with postmenopausal hormonal treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Breast cancer and hormone-replacement therapy: the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

In vivo and in vitro estrogenic and progestagenic actions of Tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tissue-selectivity: the mechanism of action of tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tibolone: a steroid with a tissue-specific mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Long-term effects of tibolone on mammographic density

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tibolone and its effects on bone: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tibolone actions on normal and breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

In vitro studies of tibolone in breast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of progestagens and Org OD14 in in vitro and in vivo tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tibolone: a compound with tissue specific inhibitory effects on sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tibolone and 5alpha-dihydrotestosterone alone or in combination with an antiandrogen in a rat breast tumour model

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of tibolone on human breast cancer cells and human vascular coronary cells

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tissue-selective effects of tibolone on the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Receptor profiling and endocrine interactions of tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

A pilot study of hormone replacement therapy with tibolone in women with mastopathic breasts

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Postmenopausal hormone therapy before and after breast cancer: clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Effects of tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: an observational follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Long-term effects of tibolone on the endometrium as assessed by bleeding episodes, transvaginal scan and endometrial biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

A review of the effects of tibolone on the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960005-9

7 January 2021

10.1016/S1028-4559(07)60005-9

Identifiers

DOI

1 reference

16 August 2017

1 reference